Savaria Corporation (“Savaria” or the “Corporation”) (TSX:SIS.TO) announced today that it has entered into an agreement (the “Acquisition Agreement”) with Span-America Medical Systems, Inc. (“Span-America”) (NASDAQ:SPAN) pursuant to which Savaria will acquire Span-America by way of an all-cash tender offer of US$29.00 per share, for a total transaction consideration of approximately US$80.2 million (or C$109.5 million) (the “Transaction”).
Shares of Span-America Medical Systems, Inc. (NASDAQ:SPAN) last traded at $28.90. The company’s performance year to date is 59.61%. The 200 day simple moving average is 50.59%. The 200 simple moving average (SMA) is considered a key indicator by traders and market analysts for determining the overall long-term trend. The price level in a market that coincides with the 200 SMA is recognized as a major support when price is above the 200 SMA or resistance when price is below the 200 SMA level.
As per recent filings, Span-America Medical Systems, Inc. (NASDAQ:SPAN) has an insider ownership of 5.00%.
SPAN-AMERICA MEDICAL SYS, INC. manufactures and distributes a variety of polyurethane foam products and contract packaging products for the medical, consumer and industrial markets.
Span-America Medical Systems, Inc. (NASDAQ:SPAN) has been storming Wallstreet with solid press release. Recently, the company announced that according to the March 2017 study commissioned by RetailMeNot and conducted by Forrester Consulting, the company’s mobile marketing solutions generate a three-year, risk-adjusted return on investment (ROI) of 4.3x.
The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions. Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.
The Exponential Moving Average (EMA) is similar to a simple moving average (average price over a set period) but it utilizes a weighting factor that exponentially declines from the most recent data point (recent prices are weighted higher than oil prices). EMA analysis compares the short term (5 days and 13 days), intermediate term (20 days) and long term (50 days) EMA’s. The respective EMA’s will give bullish signals when trading above trailing EMA’s and below the current price and vice versa. EMA alerts include crossovers (i.e the 5 day EMA crosses above/below the 20 day EMA) and EMA convergencies (5 day EMA equivalent to 13 day EMA). The long term and short term EMA’s of 24.17 and 21.63 are lower than the current trading price suggesting a bullish pattern in both short term as well as long term. .
The relative strength index (RSI) is a momentum oscillator that is able to measure the velocity and magnitude of stock price changes. Momentum is calculated as the ratio of positive price changes to negative price changes. The RSI analysis compares the current RSI against neutral(50), oversold (30) and overbought (70) conditions. Alerts will inform you when stocks recede from oversold/overbought levels or breakthrough neutral (50). The current RSI is 87.55 suggesting a bullish price action.
Span-America Medical Systems, Inc. (NASDAQ:SPAN) is all set to announce its earnings on May 11/a. As per Zack’s analyst ratings, Span-America Medical Systems, Inc. (NASDAQ:SPAN) currently has an average brokerage rating of . On a scale of 1 to 5, a rating of 1 or 2 would indicate a buy, and a rating of 4 or 5 would signify a sell recommendation. A rating of 3 would indicate a hold on the stock. The consensus target price on (NASDAQ:SPAN) is $ with a high of $ and a low of $.
As such, while we believe Span-America Medical Systems, Inc. (NASDAQ:SPAN) represents a compelling growth story exposed to several secularly attractive markets, it would be interesting to see how it fairs for long-term investors.